Thromb Haemost 1996; 76(03): 439-443
DOI: 10.1055/s-0038-1650596
Original Article
Schattauer GmbH Stuttgart

Ca2+-dependent Activation of the 33-kDa Protein Kinase Transmits Thrombin Receptor Signals in Human Platelets

Masaru Ido
1   The Department of Molecular Pathobiology, Mie University School of Medicine, Tsu-City, Mie, Japan
,
Shinya Kato
1   The Department of Molecular Pathobiology, Mie University School of Medicine, Tsu-City, Mie, Japan
,
Hiroyuki Ogawa
1   The Department of Molecular Pathobiology, Mie University School of Medicine, Tsu-City, Mie, Japan
,
Kenji Hayashi
1   The Department of Molecular Pathobiology, Mie University School of Medicine, Tsu-City, Mie, Japan
,
Yoshihiro Komada
2   The Department of Pediatrics, Mie University School of Medicine, Tsu-City, Mie, Japan
,
Xao Li Zhang
2   The Department of Pediatrics, Mie University School of Medicine, Tsu-City, Mie, Japan
,
Minoru Sakurai
2   The Department of Pediatrics, Mie University School of Medicine, Tsu-City, Mie, Japan
,
Koji Suzuki
1   The Department of Molecular Pathobiology, Mie University School of Medicine, Tsu-City, Mie, Japan
› Author Affiliations
Further Information

Publication History

Received 25 July 1995

Accepted after resubmission 24 May 1996

Publication Date:
10 July 2018 (online)

Summary

Thrombin stimulation induces a dramatic increase in the activity of the 33-kDa serine/threonine kinase (PK33) in human platelets (10). The Arg-Gly-Asp (RGD) peptide, an inhibitor of the thrombin-mediated aggregation of platelets, did not affect the PK33 activation induced by thrombin suggesting that the activation of this kinase occurs independently from platelet aggregation. To identify a potential role of Ca2+ and calmodulin in the regulation of PK33, the effect of several Ca2+/calmodulin inhibitors on the thrombin-induced activation of PK33 was assessed using denaturation/renaturation method. Pretreatment of platelets with EGTA decreased the maximum PK33 activity induced by thrombin. The chelation of both the extra- and the intracellular Ca2+ by EGTA and by acetoxymethyl ester of 5,5′ -dimethyl-bis-(<9-aminophen-oxy) ethane-N,N,N′,N′-tetraacetic acid (BAPTA-AM) decreased further the PK33 activation by thrombin. Preincubation of platelets with the anticalmodulin agent, N-(4-aminobutyl)-5-chloro-2-naphtha-lenesulfonamide (W13), inhibited markedly the activation of PK33 by thrombin, whereas the inactive structural analog N-(4-aminobutyl)-2-naphthalenesulfonamide (W12) and the myosin light chain kinase inhibitor 1 -(5-chloronaphthalene-1 -sulfonyl)-1 H-hexahydro-1,4-diaze-pine (ML9) showed very weak inhibitory effects. Treatment of resting platelets with the calcium ionophore, A23187, activated PK33 in a dose-dependent manner; phorbol 12-myristate 13-acetate enhanced this effect. However, the two foregoing agents did not induce similar degree of PK33 activities as thrombin. These results indicate that the activation of PK33 is independent of the formation of the GPIIb/IIIa-fibrinogen complex and that it might be regulated by a Ca2+-dependent pathway.

 
  • References

  • 1 Siess W. Molecular mechanisms of platelet activation. Physiol Rev 1989; 69: 58-178
  • 2 Kroll MH, Schafer AI. Biochemical mechanisms of platelet activation. Blood 1989; 74: 1181-1195
  • 3 Vu TH, Hung DH, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64: 1057-1068
  • 4 Rasmussen UB, Vouret-Craviari V, Met S, Schlesinger Y, Pages G, Pavirani A, Lecocq J, Pouyssegur J, Obberghen-Schilling fEV. cDNA cloning and expression of a hamster a-thrombin receptor coupled to Ca2+ mobilization. FEBS Lett 1991; 288: 123-128
  • 5 Brass LF, Hoxie JA, Manning DR. Signaling through G proteins and G protein-coupled receptors during platelet activation. Thromb Haemost 1993; 70: 217-223
  • 6 Lapetina EG. The signal transduction induced by thrombin in human platelets. FEBS Lett 1990; 268: 400-404
  • 7 Nishizuka Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 1988; 334: 661-665
  • 8 Kaibuchi K, Takai Y, Sawamura M, Hoshijima M, Fujikura T, Nishizuka Y. Synergistic functions of protein phosphorylation and calcium mobilization in platelet activation. J Biol Chem 1983; 258: 6701-6704
  • 9 Berridge MJ, Irvine RF. Inositol phosphates and cell signalling. Nature 1989; 341: 197-205
  • 10 Ogawa H, Ido M, Takeya H, Suzuki K. The thrombin receptor transmits signals through a 33-kDa protein kinase in human platelets. Biochem Bioph Res Co 1994; 203: 907-913
  • 11 Mann KG, Elison J, Butkowski RJ, Downing M, Nesheim ME. Prothrombin. Methods Enzymol 1981; 80: 286-302
  • 12 Vandenberghe PA, Ceuppens JL. Flow cytometric measurements of cytoplasmic free calcium in human peripheral blood T lymphocytes with fluo-3, a new fluorescent calcium indicator. J Immunol Methods 1990; 127: 197-205
  • 13 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685
  • 14 Frojmovic M, Wong T, Ven T. Dynamic measurements of the platelet membrane glycoprotein IIb-IIIa receptor for fibrinogen by flow cytometry. Biophys J 1991; 59: 815-827
  • 15 Smith JB, Selak MA, Dangelmaier C, Daniel JL. Cytosolic calcium as a second messenger for collagen-induced platelet responses. Biochem J 1992; 288: 925-929
  • 16 McNicol A, Gerrard JM. Post-receptor events associated with thrombin-induced platelet activation. Blood Coagl Fibrin 1993; 4: 975-991
  • 17 Kameshita I, Fujisawa H. A sensitive method for detection of calmodulin-dependent protein kinase II activity in sodium dodecyl sulfate-polyacryl-amide gel. Anal Biochem 1989; 183: 139-143
  • 18 Ferrell JJ, Martin GS. Thrombin stimulates the activities of multiple previously unidentified protein kinases in platelets. J Biol Chem 1989; 264: 20723-20729
  • 19 Kramer RM, Roberts EF, Strifler BA, Johnstone EM. Thrombin induces activation of p38 MAP kinase in human platelets. J Biol Chem 1995; 270: 27395-27398
  • 20 Teo M, Manser E, Lim L. Identification and molecular cloning of a p21cdc42/racl-activated serine/threonine kinase that is rapidly activated by thrombin in platelets. J Biol Chem 1995; 270: 26690-26697